Felbamate - Merck
Alternative Names: ADD 03055; CW 554; Felbamyl; Felbatol; Taloxa; W 554Latest Information Update: 02 Oct 2021
Price :
$50 *
At a glance
- Originator Meda Pharmaceuticals
- Developer AESCA; Essex Chemie; Meda Pharmaceuticals; Merck & Co
- Class Antiepileptic drugs; Phenylcarbamates; Propylene glycols; Small molecules
- Mechanism of Action NMDA receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Epilepsy; Lennox-Gastaut syndrome
Most Recent Events
- 19 Sep 2011 First generic equivalent available in USA
- 07 Dec 1999 Registered for Epilepsy in Austria (PO)
- 07 Dec 1999 Registered for Epilepsy in Belgium (PO)